SyntekaBio, Inc. 226330.KQ Stock
SyntekaBio, Inc. Price Chart
SyntekaBio, Inc. 226330.KQ Financial and Trading Overview
| SyntekaBio, Inc. stock price | 8980 KRW |
| Previous Close | 8370 KRW |
| Open | 8640 KRW |
| Bid | 8300 KRW x N/A |
| Ask | 8510 KRW x N/A |
| Day's Range | 8410 - 8980 KRW |
| 52 Week Range | 7200 - 12250 KRW |
| Volume | 284.66K KRW |
| Avg. Volume | 145.1K KRW |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.492844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
226330.KQ Valuation Measures
| Enterprise Value | 95.16B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 311.34 |
| Enterprise Value/EBITDA | -9.555 |
Trading Information
SyntekaBio, Inc. Stock Price History
| Beta (5Y Monthly) | 0.492844 |
| 52-Week Change | -17.53% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 12250 KRW |
| 52 Week Low | 7200 KRW |
| 50-Day Moving Average | 8144 KRW |
| 200-Day Moving Average | 8724.45 KRW |
226330.KQ Share Statistics
| Avg. Volume (3 month) | 145.1K KRW |
| Avg. Daily Volume (10-Days) | 271.33K KRW |
| Shares Outstanding | N/A |
| Float | 10.38M |
| Short Ratio | N/A |
| % Held by Insiders | 19.09% |
| % Held by Institutions | 0.051% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3700.68% |
| Gross Margin | 96.18% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 305.66M KRW |
| Revenue Per Share (ttm) | 22.63 KRW |
| Quarterly Revenue Growth (yoy) | -27.30% |
| Gross Profit (ttm) | 301.42M KRW |
| EBITDA | -9959461888 KRW |
| Net Income Avi to Common (ttm) | -9111824384 KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 40.07B KRW |
| Total Cash Per Share (mrq) | 2964.06 KRW |
| Total Debt (mrq) | 10.6B KRW |
| Total Debt/Equity (mrq) | 37.48 KRW |
| Current Ratio (mrq) | 24.422 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8443344384 KRW |
| Levered Free Cash Flow (ttm) | N/A |
Profile of SyntekaBio, Inc.
| Country | South Korea |
| State | N/A |
| City | Daejeon |
| Address | 1903, 1, Expo-ro |
| ZIP | N/A |
| Phone | 82 70 7663 0958 |
| Website | https://www.syntekabio.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 48 |
SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company. It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics. SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.
Q&A For SyntekaBio, Inc. Stock
What is a current 226330.KQ stock price?
SyntekaBio, Inc. 226330.KQ stock price today per share is 8980 KRW.
How to purchase SyntekaBio, Inc. stock?
You can buy 226330.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SyntekaBio, Inc.?
The stock symbol or ticker of SyntekaBio, Inc. is 226330.KQ.
How many shares does SyntekaBio, Inc. have in circulation?
The max supply of SyntekaBio, Inc. shares is 0.
What is SyntekaBio, Inc. Price to Earnings Ratio (PE Ratio)?
SyntekaBio, Inc. PE Ratio is now.
What was SyntekaBio, Inc. earnings per share over the trailing 12 months (TTM)?
SyntekaBio, Inc. EPS is 0 KRW over the trailing 12 months.
SyntekaBio, Inc. 226330.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Publishing & Printing In KQ24 | 2364.09 KRW 1.78 USD |
-1.06
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}